Protalix BioTherapeutics, Inc. Stock-Based Compensation
Protalix BioTherapeutics, Inc. (PLX) reported Stock-Based Compensation of $930.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-12
- Protalix BioTherapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $398.00K, a 6.79% decline year-over-year.
- Protalix BioTherapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $532.00K, a 1.48% decline year-over-year.
- Protalix BioTherapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $732.00K, a 11.93% increase year-over-year.
- Protalix BioTherapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $598.00K, a 3.55% decline year-over-year.
- Protalix BioTherapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $2.30M, a 29.39% decline from fiscal 2024.
- Protalix BioTherapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $3.25M, a 5.66% decline from fiscal 2023.
- Protalix BioTherapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $3.45M, a 65.37% increase from fiscal 2022.
- Protalix BioTherapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $2.08M, a 12.21% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $398.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $930.00K 10-Q · filed 2026-08-12 | $1.66M derived: sum of 3 quarters · filed 2026-08-12 | $2.26M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $532.00K 10-Q · filed 2026-05-13 | $1.26M derived: sum of 2 quarters · filed 2026-05-13 | $1.86M derived: sum of 3 quarters · filed 2026-05-13 | $2.29M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $732.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $1.33M derived: sum of 2 quarters · filed 2026-03-18 | $1.76M derived: sum of 3 quarters · filed 2026-08-12 | $2.30M 10-K · filed 2026-03-18 |
| 2025-09-30 | $598.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.02M derived: sum of 2 quarters · filed 2026-08-12 | $1.56M 10-Q · filed 2025-11-13 | $2.22M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $427.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $967.00K 10-Q · filed 2026-08-12 | $1.62M derived: sum of 3 quarters · filed 2026-08-12 | $2.24M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $540.00K 10-Q · filed 2026-05-13 | $1.19M derived: sum of 2 quarters · filed 2026-05-13 | $1.81M derived: sum of 3 quarters · filed 2026-05-13 | $2.81M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $654.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $1.27M derived: sum of 2 quarters · filed 2026-03-18 | $2.27M derived: sum of 3 quarters · filed 2026-03-18 | $3.25M 10-K · filed 2026-03-18 |
| 2024-09-30 | $620.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.62M derived: sum of 2 quarters · filed 2025-11-13 | $2.60M 10-Q · filed 2025-11-13 | $3.97M derived: sum of 4 quarters · filed 2026-03-18 |
| 2024-06-30 | $998.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.98M 10-Q · filed 2025-08-14 | $3.35M derived: sum of 3 quarters · filed 2026-03-18 | $4.44M derived: sum of 4 quarters · filed 2026-03-18 |
| 2024-03-31 | $981.00K 10-Q · filed 2025-05-09 | $2.35M derived: sum of 2 quarters · filed 2026-03-18 | $3.44M derived: sum of 3 quarters · filed 2026-03-18 | $3.88M derived: sum of 4 quarters · filed 2026-03-18 |
| 2023-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $2.46M derived: sum of 2 quarters · filed 2026-03-18 | $2.90M derived: sum of 3 quarters · filed 2026-03-18 | $3.45M 10-K · filed 2026-03-18 |
| 2023-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.53M derived: sum of 2 quarters · filed 2024-11-14 | $2.08M 10-Q · filed 2024-11-14 | $2.62M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $438.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $984.00K 10-Q · filed 2024-08-14 | $1.52M derived: sum of 3 quarters · filed 2025-03-17 | $1.95M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $546.00K 10-Q · filed 2024-05-10 | $1.08M derived: sum of 2 quarters · filed 2025-03-17 | $1.51M derived: sum of 3 quarters · filed 2025-03-17 | $1.79M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $539.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $961.00K derived: sum of 2 quarters · filed 2025-03-17 | $1.25M derived: sum of 3 quarters · filed 2025-03-17 | $2.08M 10-K · filed 2025-03-17 |
| 2022-09-30 | $422.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $710.00K derived: sum of 2 quarters · filed 2023-11-06 | $1.55M 10-Q · filed 2023-11-06 | $1.96M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | $288.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $1.12M 10-Q · filed 2023-08-07 | $1.54M derived: sum of 3 quarters · filed 2024-03-14 | $2.10M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | $836.00K 10-Q · filed 2023-05-04 | $1.25M derived: sum of 2 quarters · filed 2024-03-14 | $1.82M derived: sum of 3 quarters · filed 2024-03-14 | $2.40M derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | $418.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $981.00K derived: sum of 2 quarters · filed 2024-03-14 | $1.56M derived: sum of 3 quarters · filed 2024-03-14 | $2.38M 10-K · filed 2024-03-14 |
| 2021-09-30 | $563.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.14M derived: sum of 2 quarters · filed 2022-11-14 | $1.96M 10-Q · filed 2022-11-14 | $2.97M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $578.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.39M 10-Q · filed 2022-08-15 | $2.41M derived: sum of 3 quarters · filed 2023-02-27 | $3.82M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $816.00K 10-Q · filed 2022-05-16 | $1.83M derived: sum of 2 quarters · filed 2023-02-27 | $3.24M derived: sum of 3 quarters · filed 2023-02-27 | $3.51M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $2.43M derived: sum of 2 quarters · filed 2023-02-27 | $2.69M derived: sum of 3 quarters · filed 2023-02-27 | $3.13M 10-K · filed 2023-02-27 |
| 2020-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.68M derived: sum of 2 quarters · filed 2021-11-15 | $2.11M 10-Q · filed 2021-11-15 | $2.35M derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-06-30 | $267.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $698.00K 10-Q · filed 2021-08-16 | $934.00K derived: sum of 3 quarters · filed 2022-03-31 | $1.13M derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-03-31 | $431.00K 10-Q · filed 2021-05-14 | $667.00K derived: sum of 2 quarters · filed 2022-03-31 | $863.00K derived: sum of 3 quarters · filed 2022-03-31 | $976.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2019-12-31 | $236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $432.00K derived: sum of 2 quarters · filed 2022-03-31 | $545.00K derived: sum of 3 quarters · filed 2022-03-31 | $835.00K 10-K · filed 2022-03-31 |
| 2019-09-30 | $196.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $309.00K derived: sum of 2 quarters · filed 2020-10-29 | $599.00K 10-Q · filed 2020-10-29 | $1.02M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-06-30 | $113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $403.00K 10-Q · filed 2020-08-10 | $821.00K derived: sum of 3 quarters · filed 2021-03-30 | $843.00K derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-03-31 | $290.00K 10-Q · filed 2020-06-01 | $708.00K derived: sum of 2 quarters · filed 2021-03-30 | $730.00K derived: sum of 3 quarters · filed 2021-03-30 | $742.00K derived: sum of 4 quarters · filed 2021-03-30 |
| 2018-12-31 | $418.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $440.00K derived: sum of 2 quarters · filed 2021-03-30 | $452.00K derived: sum of 3 quarters · filed 2021-03-30 | $514.00K 10-K · filed 2021-03-30 |
| 2018-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $34.00K derived: sum of 2 quarters · filed 2019-11-07 | $96.00K 10-Q · filed 2019-11-07 | $142.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $74.00K 10-Q · filed 2019-08-08 | $120.00K derived: sum of 3 quarters · filed 2020-03-12 | $195.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $62.00K 10-Q · filed 2019-05-06 | $108.00K derived: sum of 2 quarters · filed 2020-03-12 | $183.00K derived: sum of 3 quarters · filed 2020-03-12 | $281.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $121.00K derived: sum of 2 quarters · filed 2020-03-12 | $219.00K derived: sum of 3 quarters · filed 2020-03-12 | $337.00K 10-K · filed 2020-03-12 |
| 2017-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-18 | $173.00K derived: sum of 2 quarters · filed 2019-03-18 | $291.00K 10-Q · filed 2019-03-18 | $514.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-03-18 | $216.00K 10-Q · filed 2019-03-18 | $439.00K derived: sum of 3 quarters · filed 2019-03-18 | $602.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | $118.00K 10-Q · filed 2019-03-18 | $341.00K derived: sum of 2 quarters · filed 2019-03-18 | $504.00K derived: sum of 3 quarters · filed 2019-03-18 | $731.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | $223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $386.00K derived: sum of 2 quarters · filed 2019-03-18 | $613.00K derived: sum of 3 quarters · filed 2019-03-18 | $988.00K 10-K · filed 2019-03-18 |
| 2016-09-30 | $163.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $390.00K derived: sum of 2 quarters · filed 2017-11-08 | $765.00K 10-Q · filed 2017-11-08 | $1.15M derived: sum of 4 quarters · filed 2018-03-06 |
| 2016-06-30 | $227.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $602.00K 10-Q · filed 2017-08-09 | $985.00K derived: sum of 3 quarters · filed 2018-03-06 | $1.43M derived: sum of 4 quarters · filed 2018-03-06 |
| 2016-03-31 | $375.00K 10-Q · filed 2017-05-10 | $758.00K derived: sum of 2 quarters · filed 2018-03-06 | $1.20M derived: sum of 3 quarters · filed 2018-03-06 | $1.76M derived: sum of 4 quarters · filed 2018-03-06 |
| 2015-12-31 | $383.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $829.00K derived: sum of 2 quarters · filed 2018-03-06 | $1.38M derived: sum of 3 quarters · filed 2018-03-06 | $1.80M 10-K · filed 2018-03-06 |
| 2015-09-30 | $446.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.00M derived: sum of 2 quarters · filed 2016-11-09 | $1.42M 10-Q · filed 2016-11-09 | $1.98M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $554.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $973.00K 10-Q · filed 2016-08-08 | $1.53M derived: sum of 3 quarters · filed 2017-03-16 | $1.64M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $419.00K 10-Q · filed 2016-05-09 | $978.00K derived: sum of 2 quarters · filed 2017-03-16 | $1.08M derived: sum of 3 quarters · filed 2017-03-16 | $991.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $559.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $665.00K derived: sum of 2 quarters · filed 2017-03-16 | $572.00K derived: sum of 3 quarters · filed 2017-03-16 | $1.24M 10-K · filed 2017-03-16 |
| 2014-09-30 | $106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $13.00K derived: sum of 2 quarters · filed 2015-11-09 | $683.00K 10-Q · filed 2015-11-09 | $1.32M derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-06-30 | -$93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $577.00K 10-Q · filed 2015-08-10 | $1.21M derived: sum of 3 quarters · filed 2016-03-08 | $2.17M derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-03-31 | $670.00K 10-Q · filed 2015-05-07 | $1.31M derived: sum of 2 quarters · filed 2016-03-08 | $2.26M derived: sum of 3 quarters · filed 2016-03-08 | $3.39M derived: sum of 4 quarters · filed 2016-03-08 |
| 2013-12-31 | $636.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $1.59M derived: sum of 2 quarters · filed 2016-03-08 | $2.72M derived: sum of 3 quarters · filed 2016-03-08 | $4.09M 10-K · filed 2016-03-08 |
| 2013-09-30 | $954.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $2.09M derived: sum of 2 quarters · filed 2014-11-10 | $3.45M 10-Q · filed 2014-11-10 | $5.14M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $2.50M 10-Q · filed 2014-08-07 | $4.18M derived: sum of 3 quarters · filed 2015-03-12 | $6.49M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $1.37M 10-Q · filed 2014-05-08 | $3.05M derived: sum of 2 quarters · filed 2015-03-12 | $5.36M derived: sum of 3 quarters · filed 2015-03-12 | $8.99M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $3.99M derived: sum of 2 quarters · filed 2015-03-12 | $7.62M derived: sum of 3 quarters · filed 2015-03-12 | $7.75M 10-K · filed 2015-03-12 |
| 2012-09-30 | $2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $5.94M derived: sum of 2 quarters · filed 2013-11-07 | $6.07M 10-Q · filed 2013-11-07 | $6.22M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | $3.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $3.76M 10-Q · filed 2013-08-08 | $3.92M derived: sum of 3 quarters · filed 2014-03-13 | $4.12M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | $129.00K 10-Q · filed 2013-05-09 | $285.00K derived: sum of 2 quarters · filed 2014-03-13 | $494.00K derived: sum of 3 quarters · filed 2014-03-13 | $773.00K derived: sum of 4 quarters · filed 2014-03-13 |
| 2011-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $365.00K derived: sum of 2 quarters · filed 2014-03-13 | $644.00K derived: sum of 3 quarters · filed 2014-03-13 | $886.00K 10-K · filed 2014-03-13 |
| 2011-09-30 | $209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $488.00K derived: sum of 2 quarters · filed 2012-11-07 | $730.00K 10-Q · filed 2012-11-07 | $1.13M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $279.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $521.00K 10-Q · filed 2012-08-03 | $916.00K derived: sum of 3 quarters · filed 2013-02-28 | $1.27M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $242.00K 10-Q · filed 2012-05-09 | $637.00K derived: sum of 2 quarters · filed 2013-02-28 | $992.00K derived: sum of 3 quarters · filed 2013-02-28 | |
| 2010-12-31 | $395.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $750.00K derived: sum of 2 quarters · filed 2013-02-28 | $1.28M 10-K · filed 2013-02-28 | |
| 2010-09-30 | $355.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $887.00K 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $532.00K 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | $2.68M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |